Committee approves patient‑assistance reporting amendment for drug transparency bill and sends bill to floor
The Senate Committee adopted a dash-2 amendment to SB 1528 to require drug manufacturers to report details of all patient assistance programs for Oregon consumers and forwarded the bill to the Senate floor with a due‑pass recommendation.
The full story
The Senate Committee on Health Care on Feb. 16 approved a dash-2 amendment to Senate Bill 1528 requiring drug manufacturers to report annually on all patient assistance programs, and recommended the amended bill to the Senate floor.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or